Showing results (1271-1280 of 8,960) with videos related to
Sort By:
Pageof 896
Journal of Hepatology|July 16, 2021
Fibrogenic signals persist in DAA-treated HCV patients after sustained virological responseClaudia Montaldo, Michela Terri, Veronica Riccioni, et al.Journal of Hepatology|July 21, 2021
Maternal obesity increases the risk and severity of NAFLD in offspringHannes Hagström, Tracey G Simon, Bjorn Roelstraete, et al.Journal of Hepatology|December 1, 1987
Comparison of bolus and infusion methods for estimating hepatic blood flow in patients with liver disease using indocyanine greenD Clements, R West, E EliasJournal of Hepatology|December 1, 1987
Portal hypertension in primary biliary cirrhosis. Relationship with histological featuresM Navasa, A Parés, M Bruguera, et al.Journal of Hepatology|December 1, 1987
Kupffer cell-mediated induction of synthesis and secretion of proteoglycans by rat liver fat-storing cells in cultureA M Gressner, O ZerbeJournal of Hepatology|December 3, 2020
Understanding tumour cell heterogeneity and its implication for immunotherapy in liver cancer using single-cell analysisSophia Heinrich, Amanda J Craig, Lichun Ma, et al.Journal of Hepatology|December 21, 2020
T cell receptor repertoires within liver allografts are different to those in the peripheral bloodYoung-Seon Mederacke, Mikalai Nienen, Michael Jarek, et al.Journal of Hepatology|April 17, 2013
Treatment optimization and prediction of HCV clearance in patients with acute HCV infectionAlessandra Mangia, Rosanna Santoro, Massimiliano Copetti, et al.Journal of Hepatology|April 17, 2013
How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE?Gerd Otto, Marcus Schuchmann, Maria Hoppe-Lotichius, et al.Journal of Hepatology|March 19, 2013
Everolimus does not further reduce polycystic liver volume when added to long acting octreotide: results from a randomized controlled trialMelissa Chrispijn, Tom J G Gevers, Jeroen C Hol, et al.Pageof 896